Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features

BACKGROUND: The gene EZH2, the polycomb group protein enhancer of zeste 2, encodes a transcriptional repressor that also serves as a histone methyltransferase that is associated with progression to more advanced disease in a variety of malignancies. EZH2 expression level in urothelial cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yung-Luen, Su, Kuo-Jung, Hsieh, Ming-Ju, Wang, Shian-Shiang, Wang, Po-Hui, Weng, Wei-Chun, Yang, Shun-Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972169/
https://www.ncbi.nlm.nih.gov/pubmed/24691023
http://dx.doi.org/10.1371/journal.pone.0093635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972169/
https://www.ncbi.nlm.nih.gov/pubmed/24691023
http://dx.doi.org/10.1371/journal.pone.0093635

Ejemplares similares